• Austria
  • Germany
  • Italy
  • Netherlands
  • Spain
  • Switzerland
  • UK
  • Bencard Adjuvant Systems
  • Allergy Therapeutics Plc
Allergy Therapeutics PLC
  • About us
    • About us
    • Overview
    • Mission and vision
    • Our markets
    • How we create value
    • The opportunity
    • Our stakeholders
    • Our purpose & values
    • Our code
    about_us-gif.gif

    Global pioneers of convenient treatment for allergy and immune related disorders.

  • Our science
    • Our science
    • Transforming lives
    • Delivering convenience
    • Specialist expertise
    • Research and development
      • Research and development
      • Product development
      • Investigator and Consultant Registry
      • Publications and posters
    Our science-gif.gif

    Transforming lives by delivering convience.

    Transforming lives
  • Our products
    • Our products
    • Information for Healthcare professionals
    • Information for patients
    GettyImages-587493720@2x.jpg

    As a Healthcare professional, you understand the importance of convenience in allergy treatments, because this allows you to deliver the best patient care.

    Information for healthcare professionals
  • Investors
    • Investors
    • Overview
    • At a glance
    • Investment case
      • Investment case
      • Business model
      • Strategy
    • Regulatory news
    • Email alert
    • Results, reports and presentations
    • Share tools
      • Share tools
      • Share price summary
      • Detailed share chart
      • Historical lookup
      • Share price calculator
    • Shareholder services
      • Shareholder services
      • Subscription of shares and debt financing
      • AGM information
      • GM information
      • Registrar details
      • Major shareholders
      • Analyst coverage
      • Electronic communications
      • Mandatory Cash Offer
      • Open offer
    • AIM rule 26
    • Corporate governance
      • Corporate governance
      • Board of directors
      • Our board and its committees
    • Investor And Advisor Contacts
    GettyImages-587493720@2x.jpg

    We are a visionary immunology business with specialist experience in the research and development of allergy treatments.

    At a glance
  • Sustainability
    • Sustainability
    • Overview
    • Our People
    • Our patients
    • Our communities
    • Our planet
  • Careers
    • Careers
    • Discover more
    • Culture & values
    • Our locations
    • Career areas
    • Career vacancies
    careers-nav-item-image.jpg

    Work with us.

    Career vacancies
  • Get in touch
  • Our global sites
    • Austria
    • Germany
    • Italy
    • Netherlands
    • Spain
    • Switzerland
    • UK
    • Bencard Adjuvant Systems
    • Allergy Therapeutics Plc

Publications and posters

  • Allergy Therapeutics PLC
  • Research and development
  • Publications and posters
  • Transforming lives
  • Delivering convenience
  • Specialist expertise
  • Research and development
    • Product development
    • Investigator and Consultant Registry
    • Publications and posters
Filter by:
  • All
  • Poster
  • Publication
February 2022

Tolerability, course and follow-up of specific immunotherapy using a modified ultra-rush procedure in children and adolescents with insect venom allergy.

January 2022

Long-term benefits of targeted micronutrition with the holoBLG lozenge in house dust mite allergic patients

January 2022

Micronutritional supplementation with a holoBLG-based FSMP (food for special medical purposes)-lozenge alleviates allergic symptoms in BALB/c mice: Imitating the protective farm effect.

January 2022

Impact of house dust mite‑driven asthma on children’s school performance and activity.

  • 01
  • ...
  • 07
  • 08
footer-logo.svg
Linkedin icon
Quick links Head office General inquiries Terms and Conditions Privacy Statement Cookies
Adverse Event Reporting Modern Slavery and Human Trafficking Statement Gender Pay Gap QCA Code Compliance statement
Contact us
Allergy Therapeutics, Dominion Way, Worthing, West Sussex, BN14 8SA, United Kingdom Tel +44 (0)1903 844 700
© Allergy Therapeutics 2025. By Emperor